Enhancing the expanded criteria donor policy as an intervention to improve kidney allocation: Is it actually a 'Net-Zero' model?

American Journal of Transplantation

Volumn 10, Issue 12, 2010, Pages 2582-2585

  Schold, J D ^a,b   Hall, Y N ^c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

allocation; deceased donor kidneys; expanded criteria donors; kidney transplantation; transplant centers

Indexed keywords

HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HLA MATCHING; HUMAN; INTERVENTION STUDY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIFE EXPECTANCY; MORTALITY; OUTCOME ASSESSMENT; PATIENT AUTONOMY; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL RATE; ADULT; DECEASED DONOR; EXPANDED CRITERIA DONOR; HEMODIALYSIS PATIENT; NOTE; UNITED STATES;

HEALTH CARE RATIONING; HUMANS; KIDNEY TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; WAITING LISTS;

EID: 78649878811     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03320.x     Document Type: Short Survey

References (25)

1. Alexander GC, Sehgal AR,. Barriers to cadaveric renal transplantation among blacks, women, and the poor. J Am Med Assoc 1998; 280: 1148-1152.
2. Epstein AM, Ayanian JZ, Keogh JH, et al,. Racial disparities in access to renal transplantation-Clinically appropriate or due to underuse or overuse? N Engl J Med 2000; 343: 1537-1544, 2.
3. Hall YN, O'Hare AM, Young BA, Boyko EJ, Chertow GM,. Neighborhood poverty and kidney transplantation among US Asians and Pacific Islanders with end-stage renal disease. Am J Transplant 2008; 8: 2402-2409.
4. Meier-Kriesche HU, Schold JD, Gaston RS, Wadstrom J, Kaplan B,. Kidneys from deceased donors: Maximizing the value of a scarce resource. Am J Transplant 2005; 5: 1725-1730.
5. Roberts JP, Wolfe RA, Bragg-Gresham JL, et al,. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med 2004; 350: 545-551.
6. Port FK, Bragg-Gresham JL, Metzger RA, et al,. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281-1286.
7. Definition of Expanded Donor and Standard Donor. 7-20-0010. Ref Type: Electronic Citation
8. United States Renal Data System. 2009 Annual Data Report. 8-19-2010. Ref Type: Electronic Citation
9. Wolfe RA, McCullough KP, Schaubel DE, et al,. Calculating life years from transplant (LYFT): Methods for kidney and kidney-pancreas candidates. Am J Transplant 2008; 8: 997-1011.
10. Wolfe RA, McCullough KP, Leichtman AB,. Predictability of survival models for waiting list and transplant patients: Calculating LYFT. Am J Transplant 2009; 9: 1523-1527.
11. Curtis JJ,. Ageism and kidney transplantation. Am J Transplant 2006; 6: 1264-1266.
12. Chertow GM, Brenner BM, Mackenzie HS, Milford EL,. Non-immunologic predictors of chronic renal allograft failure: Data from the United Network of Organ Sharing. Kidney Int Suppl 1995; 52: S48-S51.
13. Ojo AO, Hanson JA, Meier-Kriesche H, et al,. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and wait-listed transplant candidates. J Am Soc Nephrol 2001; 12: 589-597.
14. Schold JD, Kaplan B, Baliga RS, Meier-Kriesche HU,. The broad spectrum of quality in deceased donor kidneys. Am J Transplant 2005; 5: 757-765.
15. Merion RM, Ashby VB, Wolfe RA, et al,. Deceased-donor characteristics and the survival benefit of kidney transplantation. JAMA 2005; 294: 2726-2733.
16. Wolfe RA, Ashby VB, Milford EL, et al,. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725-1730.
17. Schnitzler MA, Whiting JF, Brennan DC, et al,. The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation 2003; 75: 1940-1945.
18. Schold JD, Meier-Kriesche HU,. Which renal transplant candidates should accept marginal kidneys in exchange for a shorter waiting time on dialysis? Clin J Am Soc Nephrol 2006; 1: 532-538.
19. Meier-Kriesche HU, Scornik JC, Susskind B, Rehman S, Schold JD,. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients. Transplantation 2009; 88: 23-29.
20. Schold J, Srinivas TR, Sehgal AR, Meier-Kriesche HU,. Half of kidney transplant candidates who are older than 60 years now placed on the waiting list will die before receiving a deceased-donor transplant. Clin J Am Soc Nephrol 2009; 4: 1239-1245.
21. Schold JD, Howard RJ, Scicchitano MJ, Meier-Kriesche HU,. The expanded criteria donor policy: An evaluation of program objectives and indirect ramifications. Am J Transplant 2006; 6: 1689-1695.
22. Sung RS, Guidinger MK, Leichtman AB, et al,. Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation 2007; 84: 1138-1144.
23. Grams ME, Womer KL, Ugarte RM, Desai NM, Montgomery RA, Segev DL,. Listing for expanded criteria donor kidneys in older adults and those with predicted benefit. Am J Transplant 2010; 10: 802-809.
24. Rao PS, Schaubel DE, Guidinger MK, et al,. A comprehensive risk quantification score for deceased donor kidneys: The kidney donor risk index. Transplantation 2009; 88: 231-236.
25. Evans RW, Manninen DL, Garrison LP, Jr,. et al. (The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-559.